Trouver Injection De Progestérone, Protection Féminine, Médecine Finie dans le répertoire Industry, Reliable Fabricant / Fournisseur / Factory de Chine

Panier (0)
Comprimé pharmaceutique de potassium d'Amo et de Clavulanate
Accueil > Liste de Produits > Antibiotiques médicaux > Comprimé pharmaceutique de potassium d'Amo et de Clavulanate

Comprimé pharmaceutique de potassium d'Amo et de Clavulanate

    Type de paiement: L/C, T/T, D/P, Western Union, Paypal
    Quantité de commande minimum: 10
    Délai de livraison: 1 jours
    productivité: 60000000
    Lieu d'origine:  Chine
    Capacité d'approvisionnement: 60000000

Informations de base

Modèle:  amo-1

Description du produit

N ° de Modèle: amo-1 Mode d'Emploi: Pour administration par voie orale Etat: Solide Type: Produits Biologiques Couleur: comme Votre Exigence Spécification: 0.625g Code SH: 2620999090 Application: Médecine Intérieure Convient pour: Adulte Forme: Tablette Technologie Pharmaceutique: Synthèse Chimique : OEM Origine: Chine Description du produit: \ nclavulanate potasse \ n

Product:

 

Indications


Otitis media, sinusitis, pharyngitis, tonsillitis, urinary tract infections, skin and soft tissue infections, acute bronchitis, pneumonia, gonorrhea, typhoid, infectious diseases, sexually transmitted diseases, dermatology, renal medicine, respiratory medicine, ENT, purulent pleurisy, hepatobiliary system infections, sepsis, dysentery.

Dosage

Oral.
1, adults once 0.5g, every 6 to 8 hours a day dose does not exceed 4g.
2, children daily dose according to body weight 20 ~ 40mg / kg, every 8 hours; three months following the baby daily dose according to the weight 30mg / kg, every 12 hours.
3, patients with severe renal impairment need to adjust the dose, which endogenous creatinine clearance rate of 10 ~ 30ml / min in patients with 0.25 ~ 0.5g every 12 hours; patients with creatinine clearance less than 10ml / min 0.25 per 24 hours ~ 0.5g.

Adverse reactions


1. Nausea, vomiting, diarrhea and pseudomembranous colitis and other gastrointestinal reactions.
2. Rash, drug fever and asthma and other allergic reactions.
3. Anemia, thrombocytopenia, eosinophilia cells.
4. Serum aminotransferase may be slightly increased.
5. Caused by the Candida or resistant superinfection.
6. Occasionally excitement, anxiety, insomnia, dizziness, and behavioral abnormalities, central nervous system symptoms.

Taboo

test-positive patients allergic to penicillin and penicillin skin disabled.

NOTES


1. It must be done before using sodium penicillin skin test positive for the banned.
2. Infectious mononucleosis in patients with the FDA should be prone to rash, should be avoided.
3. Longer course of treatment patients should check liver and kidney function and blood.
 
5. It should be used with caution in the following cases:
(1) have asthma, a history of hay fever and other allergic diseases.
(2) may have to adjust the dose elderly and severe renal impairment

Groupes de Produits : Antibiotiques médicaux